A Viral Genome Landscape of RNA Polyadenylation from KSHV Latent to Lytic Infection

RNA polyadenylation (pA) is one of the major steps in regulation of gene expression at the posttranscriptional level. In this report, a genome landscape of pA sites of viral transcripts in B lymphocytes with Kaposi sarcoma-associated herpesvirus (KSHV) infection was constructed using a modified PA-seq strategy. We identified 67 unique pA sites, of which 55 could be assigned for expression of annotated ∼90 KSHV genes. Among the assigned pA sites, twenty are for expression of individual single genes and the rest for multiple genes (average 2.7 genes per pA site) in cluster-gene loci of the genome. A few novel viral pA sites that could not be assigned to any known KSHV genes are often positioned in the antisense strand to ORF8, ORF21, ORF34, K8 and ORF50, and their associated antisense mRNAs to ORF21, ORF34 and K8 could be verified by 3′RACE. The usage of each mapped pA site correlates to its peak size, the larger (broad and wide) peak size, the more usage and thus, the higher expression of the pA site-associated gene(s). Similar to mammalian transcripts, KSHV RNA polyadenylation employs two major poly(A) signals, AAUAAA and AUUAAA, and is regulated by conservation of cis-elements flanking the mapped pA sites. Moreover, we found two or more alternative pA sites downstream of ORF54, K2 (vIL6), K9 (vIRF1), K10.5 (vIRF3), K11 (vIRF2), K12 (Kaposin A), T1.5, and PAN genes and experimentally validated the alternative polyadenylation for the expression of KSHV ORF54, K11, and T1.5 transcripts. Together, our data provide not only a comprehensive pA site landscape for understanding KSHV genome structure and gene expression, but also the first evidence of alternative polyadenylation as another layer of posttranscriptional regulation in viral gene expression.

[1]  I. Mattaj,et al.  The influence of 5′ and 3′ end structures on pre-mRNA metabolism , 1995, Journal of Cell Science.

[2]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[3]  M. Zavolan,et al.  Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation , 2013, Genome research.

[4]  Satoko Matsumura,et al.  Activation of the Kaposi's Sarcoma-Associated Herpesvirus Major Latency Locus by the Lytic Switch Protein RTA (ORF50) , 2005, Journal of Virology.

[5]  J. Yates,et al.  Molecular architecture of the human pre-mRNA 3' processing complex. , 2009, Molecular cell.

[6]  Terrence S. Furey,et al.  F-Seq: a feature density estimator for high-throughput sequence tags , 2008, Bioinform..

[7]  M. Borowitz,et al.  A New Primary Effusion Lymphoma-Derived Cell Line Yields a Highly Infectious Kaposi's Sarcoma Herpesvirus-Containing Supernatant , 2000, Journal of Virology.

[8]  H. Martinson,et al.  Assembly of the Cleavage and Polyadenylation Apparatus Requires About 10 Seconds In Vivo and Is Faster for Strong than for Weak Poly(A) Sites , 1999, Molecular and Cellular Biology.

[9]  Karen Usdin,et al.  The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. , 2008, Genome research.

[10]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[11]  B. Tian,et al.  Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. , 2005, RNA.

[12]  D. Ganem,et al.  Array-Based Transcript Profiling and Limiting-Dilution Reverse Transcription-PCR Analysis Identify Additional Latent Genes in Kaposi's Sarcoma-Associated Herpesvirus , 2010, Journal of Virology.

[13]  Bin Tian,et al.  A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.

[14]  M. Wickens,et al.  Life and death in the cytoplasm: messages from the 3' end. , 1997, Current opinion in genetics & development.

[15]  Yan Wang,et al.  Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: cis-Acting Requirements for Replication and ori-Lyt-Associated RNA Transcription , 2004, Journal of Virology.

[16]  K. Yamanegi,et al.  Gene Structure and Expression of Kaposi's Sarcoma-Associated Herpesvirus ORF56, ORF57, ORF58, and ORF59 , 2006, Journal of Virology.

[17]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Gwack,et al.  Global Changes in Kaposi's Sarcoma-Associated Virus Gene Expression Patterns following Expression of a Tetracycline-Inducible Rta Transactivator , 2003, Journal of Virology.

[19]  S. Talbot,et al.  A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA. , 2004, The Journal of general virology.

[20]  S. Steinberg,et al.  Stability of a Long Noncoding Viral RNA Depends on a 9-nt Core Element at the RNA 5' End to Interact with Viral ORF57 and Cellular PABPC1 , 2011, International journal of biological sciences.

[21]  C. Hung,et al.  Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus. , 2012, Virus research.

[22]  K. Nishida,et al.  Mechanisms and consequences of alternative polyadenylation. , 2011, Molecules and Cells.

[23]  Yuan Chang,et al.  Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes , 2011, BMC Genomics.

[24]  P. Moore,et al.  Transcriptional Analysis of Latent and Inducible Kaposi's Sarcoma-Associated Herpesvirus Transcripts in the K4 to K7 Region , 2005, Journal of Virology.

[25]  D. Ganem,et al.  Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. , 2009, Cell host & microbe.

[26]  J. Alwine,et al.  Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences , 1989, Molecular and cellular biology.

[27]  R. Sun,et al.  Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Sun,et al.  Kinetics of Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression , 1999, Journal of Virology.

[29]  E Pauws,et al.  Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: implications for SAGE analysis. , 2001, Nucleic acids research.

[30]  A. Iwamoto,et al.  Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. , 2000, Blood.

[31]  Satoko Matsumura,et al.  Transcripts Encoding K12, v-FLIP, v-Cyclin, and the MicroRNA Cluster of Kaposi's Sarcoma-Associated Herpesvirus Originate from a Common Promoter , 2005, Journal of Virology.

[32]  G. Hayward,et al.  Patterns of Gene Expression and a Transactivation Function Exhibited by the vGCR (ORF74) Chemokine Receptor Protein of Kaposi's Sarcoma-Associated Herpesvirus , 2002, Journal of Virology.

[33]  Zhi-Ming Zheng,et al.  Kaposi's Sarcoma-Associated Herpesvirus ORF57 Is Not a Bona Fide Export Factor , 2012, Journal of Virology.

[34]  Yan Wang,et al.  Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: DualRole of Replication and Transcription Activator , 2006, Journal of Virology.

[35]  Job Harms,et al.  THE LANDSCAPE OF , 2010 .

[36]  S. Vagner,et al.  Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation , 2009, Nucleic acids research.

[37]  B. Séraphin,et al.  Cryptic Pol II Transcripts Are Degraded by a Nuclear Quality Control Pathway Involving a New Poly(A) Polymerase , 2005, Cell.

[38]  Sayan Mukherjee,et al.  Genome-wide identification and predictive modeling of tissue-specific alternative polyadenylation , 2013, Bioinform..

[39]  D. Ganem,et al.  Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells , 1999, Journal of Virology.

[40]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Uwe Ohler,et al.  Distinct polyadenylation landscapes of diverse human tissues revealed by a modified PA-seq strategy , 2013, BMC Genomics.

[42]  J. Graber,et al.  A multispecies comparison of the metazoan 3'-processing downstream elements and the CstF-64 RNA recognition motif , 2006, BMC Genomics.

[43]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[44]  Zhi-Ming Zheng,et al.  Kaposi's Sarcoma-associated Herpesvirus K8 Exon 3 Contains Three 5′-Splice Sites and Harbors a K8.1 Transcription Start Site* , 2002, The Journal of Biological Chemistry.

[45]  J. Wilusz,et al.  Auxiliary downstream elements are required for efficient polyadenylation of mammalian pre-mRNAs. , 1998, Nucleic acids research.

[46]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[47]  T. D. Schneider,et al.  Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.

[48]  Blossom Damania,et al.  Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  K. Kaye,et al.  The Kaposi's Sarcoma-Associated Herpesvirus K12 Transcript from a Primary Effusion Lymphoma Contains Complex Repeat Elements, Is Spliced, and Initiates from a Novel Promoter , 2002, Journal of Virology.

[50]  D. Ganem,et al.  Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility , 2011, Proceedings of the National Academy of Sciences.

[51]  M. Kruhlak,et al.  Interplay between Polyadenylate-Binding Protein 1 and Kaposi's Sarcoma-Associated Herpesvirus ORF57 in Accumulation of Polyadenylated Nuclear RNA, a Viral Long Noncoding RNA , 2012, Journal of Virology.

[52]  J. Manley,et al.  Mechanism and regulation of mRNA polyadenylation. , 1997, Genes & development.

[53]  D. Ganem,et al.  The Lytic Transcriptome of Kaposi's Sarcoma-Associated Herpesvirus Reveals Extensive Transcription of Noncoding Regions, Including Regions Antisense to Important Genes , 2010, Journal of Virology.

[54]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[55]  K. Yamanegi,et al.  Structural and Functional Analyses of Kaposi Sarcoma-associated Herpesvirus ORF57 Nuclear Localization Signals in Living Cells* , 2006, Journal of Biological Chemistry.

[56]  J. Wilusz,et al.  The G-rich auxiliary downstream element has distinct sequence and position requirements and mediates efficient 3' end pre-mRNA processing through a trans-acting factor. , 1995, Nucleic acids research.

[57]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[58]  P. Moore,et al.  Characterization and Cell Cycle Regulation of the Major Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter , 1999, Journal of Virology.

[59]  S. Le,et al.  Kaposi's Sarcoma-Associated Herpesvirus ORF57 Promotes Escape of Viral and Human Interleukin-6 from MicroRNA-Mediated Suppression , 2011, Journal of Virology.

[60]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[61]  C. Boshoff,et al.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. , 2000, Blood.

[62]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[63]  M. Gerstein,et al.  The Transcriptional Landscape of the Yeast Genome Defined by RNA Sequencing , 2008, Science.

[64]  M. Kruhlak,et al.  Kaposi's sarcoma‐associated herpesviral IL‐6 and human IL‐6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation , 2011, The Journal of pathology.

[65]  D. Ganem,et al.  Making Sense of Antisense: Seemingly Noncoding RNAs Antisense to the Master Regulator of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Do Not Regulate That Transcript but Serve as mRNAs Encoding Small Peptides , 2010, Journal of Virology.

[66]  F. Zhu,et al.  Identification of the Immediate-Early Transcripts of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.

[67]  Sebastian D. Mackowiak,et al.  The Landscape of C. elegans 3′UTRs , 2010, Science.

[68]  N. Proudfoot,et al.  Transcriptional Termination Enhances Protein Expression in Human Cells , 2009, Molecular cell.